Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Endocyte, Inc. (ECYT)

« Back to company index

ECYT Chatter Timeline

Stock Ticker for ECYT

Most Active Tweeters for ECYT

No tweets found

Recent Tweets for ECYT

chiragontwtr @chiragontwtr
@rhoman1996 @MaxPowerNGS $ECYT too was trying since 1990 if not before and still had not brought a single drug to m… https://t.co/QA8K9LKI1J
March 31st 2019, 6:03am
chiragontwtr @chiragontwtr
Removed $ECYT from watchlist. Will be missed as one of the top most gainers for me.
March 21st 2019, 11:03pm
TheMarketsDaily @TheMarketsDaily
Analyzing Endocyte $ECYT and Imprimis Pharmaceuticals $IMMY https://t.co/aV3iLxhxPO
March 19th 2019, 2:03am
DiscoveryDrug @DiscoveryDrug
RT @DiscoveryDrug: $IMGN Ph3 failure is third drug targeting folate receptor failed in pivotal trials after $ECYT's vintafolide and EisaiMo…
March 2nd 2019, 8:03pm
thefinreviewer @thefinreviewer
Comparing of Osiris Therapeutics Inc. $ECYT https://t.co/I3rLYsbo4N
March 2nd 2019, 1:03pm
bulletin_en @bulletin_en
Ghost Tree Capital LLC Increased Its Stake in Endocyte INC $ECYT by $10.20 Million as Shares Rose https://t.co/xWE55b97tw
March 2nd 2019, 11:03am
mmahotstuff1 @mmahotstuff1
What's Next for Endocyte Inc $ECYT After Having More Shares Shorted? https://t.co/OaqhjDYqTc
March 2nd 2019, 10:03am
WeekHerald @WeekHerald
Endocyte, Inc. $ECYT Receives Average Rating of “Buy” from Analysts https://t.co/RKhFNP1sWA
March 1st 2019, 11:03pm
amitkjolly @amitkjolly
RT @AndyBiotech: $IMGN Ph3 failure is third drug targeting folate receptor failed in pivotal trials after $ECYT's vintafolide and Eisai/Mor…
March 1st 2019, 1:03pm
DiscoveryDrug @DiscoveryDrug
$IMGN Ph3 failure is third drug targeting folate receptor failed in pivotal trials after $ECYT's vintafolide and Ei… https://t.co/1urmMifXEc
March 1st 2019, 8:03am
AAMortazavi @AAMortazavi
@adamfeuerstein Sorry there was $ECYT too... hmm
March 1st 2019, 7:03am
AndyBiotech @AndyBiotech
$IMGN Ph3 failure is third drug targeting folate receptor failed in pivotal trials after $ECYT's vintafolide and Ei… https://t.co/gFcHxlITOA
March 1st 2019, 7:03am
ByMadeleineA @ByMadeleineA
RT @JacobPlieth: ...not to mention the previous lesson of $ECYT as to the suitability of the folate receptor as a target https://t.co/gOr8Z…
March 1st 2019, 7:03am
JacobPlieth @JacobPlieth
...not to mention the previous lesson of $ECYT as to the suitability of the folate receptor as a target https://t.co/gOr8Zn6JHJ $IMGN
March 1st 2019, 7:03am
ThisLincolnian @ThisLincolnian
Endocyte, Inc. $ECYT Given Consensus Recommendation of “Buy” by Brokerages https://t.co/A3LxPawZvB
February 27th 2019, 5:02pm
RyanSTTrader @RyanSTTrader
$ECYT Gone not forgotten
February 25th 2019, 7:02am
bibeypost_stock @bibeypost_stock
Endocyte INC $ECYT Shareholder Ghost Tree Capital LLC Raised Stake by $10.20 Million https://t.co/5jknxnXnCa
February 24th 2019, 9:02am
AmericanBanking @AmericanBanking
Endocyte, Inc. $ECYT Receives Average Rating of “Buy” from Brokerages https://t.co/F55b5wMmeL #stocks
February 22nd 2019, 1:02am
thefinreviewer @thefinreviewer
Comparison of BioTime Inc. $ECYT https://t.co/j369BcvhqL
February 21st 2019, 11:02pm
whatsonthorold2 @whatsonthorold2
Could Endocyte Inc $ECYT Skyrocket? The Stock Has Too Many Sellers https://t.co/pTJ3SbGFyH
February 21st 2019, 8:02am
reurope_stock @reurope_stock
A Reversal for Endocyte Inc $ECYT Is Not Near. The Stock Has Rise in Shorts https://t.co/z2g8PFxipD
February 21st 2019, 8:02am
thefinreviewer @thefinreviewer
Reviewing Nightstar Therapeutics plc $ECYT's results https://t.co/Pp1YTdFwbm
February 19th 2019, 6:02am
bulletin_en @bulletin_en
Reviewing Magenta Therapeutics Inc. $ECYT's results https://t.co/WlxcbW8eJJ
February 18th 2019, 8:02pm
Allstocknews @Allstocknews
$ECYT New Form SC 13G/A for Endocyte, Inc. From our Stock News Alerts App
February 14th 2019, 5:02pm
riverstonecap @riverstonecap
@AndyBiotech NVS's acquisition of $ECYT and its radio ligand drug can't be overlooked
February 14th 2019, 4:02pm
RyanSTTrader @RyanSTTrader
@NohupMy I did notice - we shall see. I was proven wrong before with $ECYT and got roasted. Wouldn’t be surprised i… https://t.co/E9ltVukJzz
February 14th 2019, 2:02am
thefinreviewer @thefinreviewer
Comparison of Aptinyx Inc. $ECYT https://t.co/TnS3G5y6mc
February 12th 2019, 7:02pm
thefinreviewer @thefinreviewer
Reviewing Heat Biologics Inc. $ECYT's results https://t.co/JTjK76o9Ti
February 12th 2019, 1:02pm
mmahotstuff1 @mmahotstuff1
Endocyte Inc $ECYT on Focus After Report of More Shorts https://t.co/OOAgq2Zaeo
February 12th 2019, 9:02am
bibeypost_stock @bibeypost_stock
Does Endocyte Inc $ECYT Have Gas After Even More Sellers Involved? https://t.co/ItvdxTOBID
February 12th 2019, 9:02am
teebizy @teebizy
RT @reurope_stock: Endocyte Inc $ECYT Stock Is Shorted More https://t.co/NxlrT99klr
February 12th 2019, 9:02am
reurope_stock @reurope_stock
Endocyte Inc $ECYT Stock Is Shorted More https://t.co/NxlrT99klr
February 12th 2019, 9:02am
thefinreviewer @thefinreviewer
Reviewing Marker Therapeutics Inc. $ECYT's results https://t.co/aIjX2z25r3
February 12th 2019, 2:02am
thefinreviewer @thefinreviewer
Heat Biologics Inc. $ECYT Comparison side by side https://t.co/ULjoqrtI54
February 11th 2019, 12:02pm
kreviewer1 @kreviewer1
Endocyte Inc $ECYT Stock Price Up as Sentiment Increases, now at 2.05 https://t.co/EjgcBcKCo3
February 7th 2019, 10:02am
reurope_stock @reurope_stock
Endocyte INC $ECYT Shareholder Ghost Tree Capital LLC Has Boosted Position https://t.co/KjMZ7gQmm6
February 5th 2019, 3:02pm
thefinreviewer @thefinreviewer
Comparison of Kazia Therapeutics Limited $ECYT https://t.co/eCh7VtDsGV
February 5th 2019, 3:02pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: @mic_h_el guess cash is about $1.50 alone ? $ECYT scenario ?
February 5th 2019, 11:02am
kreviewer1 @kreviewer1
As Endocyte INC $ECYT Shares Rose, Ghost Tree Capital LLC Increased Stake by $10.20 Million https://t.co/sQds54oPyZ
February 5th 2019, 10:02am
TranscriptDaily @TranscriptDaily
Endocyte, Inc. $ECYT Given Consensus Rating of “Buy” by Brokerages https://t.co/aIVBarzlrb
February 4th 2019, 2:02pm
bbnsnews @bbnsnews
Endocyte, Inc. $ECYT Receives $21.00 Average PT from Brokerages https://t.co/pPzEydgZlC
February 2nd 2019, 1:02pm
thefinreviewer @thefinreviewer
Contrasting of Innoviva Inc. $ECYT https://t.co/D9HUSNE7dG
January 30th 2019, 3:01pm
zbiotech @zbiotech
RT @bio_clouseau: $NVS PSMA radioligand for mCRPC now expected to readout rPFS in 2020. Previous guidance was Q4 19 from $ECYT
January 30th 2019, 6:01am
bio_clouseau @bio_clouseau
$NVS PSMA radioligand for mCRPC now expected to readout rPFS in 2020. Previous guidance was Q4 19 from $ECYT
January 30th 2019, 6:01am
kreviewer1 @kreviewer1
Big Money Sentiment About Endocyte Inc $ECYT Increased to 2.05 https://t.co/9oDBnf8T1v
January 29th 2019, 1:01pm
AmericanBanking @AmericanBanking
Endocyte, Inc. $ECYT Given Average Rating of “Buy” by Brokerages https://t.co/w6S3DrNhv6 #stocks
January 28th 2019, 1:01am
ZolmaxNews @ZolmaxNews
Endocyte, Inc. $ECYT Given Average Rating of “Buy” by Brokerages https://t.co/r3xDcUyrRk
January 28th 2019, 1:01am
thefinreviewer @thefinreviewer
Reviewing SELLAS Life Sciences Group Inc. $ECYT's results https://t.co/jJslqjxQ9t
January 27th 2019, 7:01pm
thefinreviewer @thefinreviewer
Reviewing Phio Pharmaceuticals Corp. $ECYT's results https://t.co/DKM9vB4cEG
January 25th 2019, 12:01am
UlmHi @UlmHi
Midatech Pharma Plc $ECYT Comparing side by side https://t.co/wDua3wTG9q
January 24th 2019, 10:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.